CME Group (CME) Revenue — Quarter Ended Mar 31, 2026
Revenue for the quarter increased compared to both the prior quarter and the same quarter last year, propelled by higher trading volume and greater interest earned on collateral reinvestment per the company's discussion. The filing notes that net cash from operations improved largely due to these factors.
Key takeaway
Quarter ended Mar 31, 2026 · FY2026 Q1
Revenue for the quarter increased compared to both the prior quarter and the same quarter last year, propelled by higher trading volume and greater interest earned on collateral reinvestment per the company's discussion. The filing notes that net cash from operations improved largely due to these factors.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.9B
Revenue reported for this quarter.
Quarter-over-quarter
+14.0%
Change from the immediately preceding quarter.
Year-over-year
+14.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$6.8B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2025 | $1.7B | +10.4% |
| Sep 30, 2025 | $1.5B | -3.0% |
| Dec 31, 2025 | $1.6B | +8.1% |
| Mar 31, 2026 | $1.9B | +14.5% |
Revenue performance
Revenue rose from the immediately preceding quarter, reversing a prior decline, and also exceeded the level achieved in the same quarter one year earlier.
Quarterly comparison
Compared with the prior quarter, revenue was higher; compared with the same quarter a year ago, revenue was also higher.
What to watch
Sustained trading volume and the trajectory of interest income from collateral reinvestment remain key factors to monitor.